0000950170-24-013474.txt : 20240209 0000950170-24-013474.hdr.sgml : 20240209 20240209192621 ACCESSION NUMBER: 0000950170-24-013474 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240207 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bensen Daniel CENTRAL INDEX KEY: 0001880946 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40800 FILM NUMBER: 24617003 MAIL ADDRESS: STREET 1: C/O TYRA BIOSCIENCES, INC STREET 2: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tyra Biosciences, Inc. CENTRAL INDEX KEY: 0001863127 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831476348 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (619) 728-4760 MAIL ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 ownership.xml 4 X0508 4 2024-02-07 0001863127 Tyra Biosciences, Inc. TYRA 0001880946 Bensen Daniel C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET CARLSBAD CA 92008 false true false false Chief Operating Officer true Common Stock 2024-02-07 4 S false 9587 18.0939 D 452981 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.48. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. /s/ Ali D. Fawaz, Attorney-in-Fact 2024-02-09